DRC’s Ebola Outbreak Is Now the Second-Largest on Record — and There Is No Vaccine for This Strain

An Ebola epidemic caused by the Bundibugyo ebolavirus — a strain for which no licensed vaccine or approved treatment exists — has spread across eastern Democratic Republic of the Congo and into Uganda, becoming the second-largest Ebola outbreak ever recorded and the fastest-growing in history [1, 2]. As of June 23, 2026, the DRC Ministry of Health reported 1,094 confirmed cases, 277 confirmed deaths, and 387 patients still hospitalized in isolation; the outbreak is the 17th Ebola epidemic in DRC’s recorded history and began only five months after the end of the previous one [1]. The World Health Organization declared the epidemic a Public Health Emergency of International Concern on May 17, 2026; on June 5, the Africa Centres for Disease Control and Prevention and the WHO jointly launched a continental preparedness and response plan requiring $518 million in donor funding [1, 4]. A critical medical obstacle is that the circulating Bundibugyo strain is entirely distinct from the Zaire ebolavirus for which the approved Ervebo vaccine was developed; WHO reviewed preliminary animal-study data suggesting partial cross-protection and ruled it insufficient to authorize Ervebo’s use, leaving response teams without any vaccine tool [2]. Uganda has already recorded two confirmed deaths, indicating cross-border containment failed at its first test [1].

Why It Sucks:

Congolese Communities in Affected Zones

• They are fighting Ebola inside an active armed conflict. The outbreak is centered in eastern DRC — a region that has endured decades of armed groups, mass displacement, and collapsing food security; the ongoing insecurity prevents health workers from safely accessing many affected communities, and populations traumatized by years of violence have deep distrust of outside intervention [4].
• There is no treatment and no vaccine for this strain. The Bundibugyo virus can kill up to 50 percent of those it infects; patients are receiving supportive care only, in isolation units operating inside resource-depleted facilities, because every approved Ebola therapeutic and vaccine targets a different species of the virus entirely [2].
• This is the country’s 17th Ebola outbreak in recorded history. DRC communities have cycled through this same disaster — isolation, contact tracing, mass fear, and economic disruption — 17 times without the international community ever resolving the underlying infrastructure and conflict failures that allow the virus to return within months of each prior outbreak’s end [1].

Global Health Organizations (WHO and Africa CDC)

• The only tools available are the ones that failed to prevent 16 prior outbreaks. WHO and the Africa CDC are deploying surveillance, contact tracing, and community engagement — the same response architecture used in every previous DRC Ebola outbreak — because no Bundibugyo-specific vaccine or therapeutic is ready for deployment; researchers are urgently evaluating candidates but no field-ready product is imminent [2].
• The $518 million plan reveals chronic preparedness underfunding. The joint continental response plan launched June 5 requires $518 million simply to equip African countries to detect and contain the current outbreak; the fact that this infrastructure does not exist after 16 prior DRC Ebola crises and a global pandemic reflects how consistently donors have allowed preparedness investment to lapse between emergencies [1, 4].
• Uganda’s confirmed deaths mean cross-border containment has already broken down. Two deaths confirmed in Uganda signal that the outbreak has crossed an international border, forcing WHO to coordinate a multi-country response simultaneously while still trying to suppress the primary epidemic inside DRC — a compounding operational burden that strains an already under-resourced response [1].

Western Donor Governments

• They are being asked for $518 million as aid budgets face sustained pressure. The joint continental response plan explicitly requires emergency international funding at a moment when foreign aid budgets in several major donor nations are under significant political pressure; aid organizations have warned that the resulting funding gap risks leaving the response chronically underpowered relative to the outbreak’s pace [4].
• Donor fatigue is real after 16 outbreaks and a global pandemic. Governments that have repeatedly funded DRC Ebola responses — often watching the same communities experience a new outbreak within months — are under domestic pressure to show durable results for their investments; the outbreak’s recurrence just five months after the 16th crisis ended makes that accountability argument exceptionally difficult to make to legislatures [1, 4].
• No vaccine means no defined endpoint for donor commitments. When Zaire-strain Ebola outbreaks occur, ring vaccination has provided a reliable containment ceiling and a reasonably predictable end date for international response efforts; the Bundibugyo strain’s lack of a licensed vaccine removes that endpoint entirely, leaving donor commitments open-ended with no clear off-ramp [2].

Sources & Citations:

[1] WHO: Ebola outbreak — DRC 2026
[2] Gavi: Bundibugyo, the rare virus causing a deadly new Ebola outbreak, has no vaccine yet
[3] CDC: Ebola Outbreak: Current Situation
[4] UN News: Ebola outbreak in DR Congo collides with conflict and hunger, WHO warns